AJ Lanigan: Certainly. In Actual fact, pharma businesses are earning huge money with remedies like Keytruda and Opdivo that offer with PD-1 and PD-L1. Here’s the super cool portion: imagine checkpoints as visitors alerts. You don’t want an immune process that’s working wild like a freight train above a cliff. waiting for link from Social Bookmarking (2)